Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Cooper

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Annals of the Rheumatic Diseases|June 25, 2009
Synergistic induction of local glucocorticoid generation by inflammatory cytokines and glucocorticoids: implications for inflammation associated bone lossK Kaur, R Hardy, M M Ahasan, et al.
Molecular Pharmaceutics|July 4, 2014
PET and SPECT imaging of a radiolabeled minigastrin analogue conjugated with DOTA, NOTA, and NODAGA and labeled with (64)Cu, (68)Ga, and (111)InS Roosenburg, P Laverman, L Joosten, et al.
Arthritis Research & Therapy|August 3, 2019
Therapeutic glucocorticoids prevent bone loss but drive muscle wasting when administered in chronic polyarthritisC G Fenton, J M Webster, C S Martin, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Annals of the Rheumatic Diseases|June 25, 2009
Synergistic induction of local glucocorticoid generation by inflammatory cytokines and glucocorticoids: implications for inflammation associated bone lossK Kaur, R Hardy, M M Ahasan, et al.
Molecular Pharmaceutics|July 4, 2014
PET and SPECT imaging of a radiolabeled minigastrin analogue conjugated with DOTA, NOTA, and NODAGA and labeled with (64)Cu, (68)Ga, and (111)InS Roosenburg, P Laverman, L Joosten, et al.
Arthritis Research & Therapy|August 3, 2019
Therapeutic glucocorticoids prevent bone loss but drive muscle wasting when administered in chronic polyarthritisC G Fenton, J M Webster, C S Martin, et al.
Pageof 6